No Data
No Data
HealthEquity Is Maintained at Overweight by Wells Fargo
HealthEquity Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains HealthEquity(HQY.US) With Buy Rating, Raises Target Price to $110
Wells Fargo analyst Stan Berenshteyn maintains $HealthEquity(HQY.US)$ with a buy rating, and adjusts the target price from $107 to $110.According to TipRanks data, the analyst has a success rate of 59
Express News | HealthEquity, Inc. : Wells Fargo Raises Target Price to $110 From $107
Why HealthEquity (HQY) Is a Top Growth Stock for the Long-Term
Wasatch Small Cap Growth Strategy's Investment in HealthEquity (HQY) Paid Off in Q1
HealthEquity(HQY.US) Officer Sells US$813.3K in Common Stock
$HealthEquity(HQY.US)$ Officer Neeleman Stephen sold 9,564 shares of common stock on Jun 6, 7, 2024 at an average price of $85.0379 for a total value of $813.3K.Source: Announcement What is statement